FEDERATED HERMES, INC. - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 98 filers reported holding INSYS THERAPEUTICS INC NEW in Q1 2019. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2019$4,000
+33.3%
7770.0%0.00%
Q4 2018$3,000
-62.5%
7770.0%0.00%
Q3 2018$8,000
+33.3%
7770.0%0.00%
Q2 2018$6,000
+20.0%
7770.0%0.00%
Q1 2018$5,000
-54.5%
777
-33.5%
0.00%
Q4 2017$11,000
+10.0%
1,1680.0%0.00%
Q3 2017$10,000
-68.8%
1,168
-53.4%
0.00%
Q2 2017$32,000
-23.8%
2,506
-36.9%
0.00%
Q1 2017$42,000
-90.2%
3,972
-91.5%
0.00%
-100.0%
Q4 2016$428,000
-65.5%
46,496
-55.9%
0.00%
-75.0%
Q3 2016$1,242,000
-30.8%
105,331
-24.0%
0.00%
-20.0%
Q2 2016$1,794,000
+3.2%
138,643
+27.6%
0.01%0.0%
Q1 2016$1,738,000
+320.8%
108,691
+652.2%
0.01%
+400.0%
Q4 2015$413,000
+41200.0%
14,449
+288880.0%
0.00%
Q3 2015$1,000
-100.0%
5
-100.0%
0.00%
-100.0%
Q1 2015$3,430,000
+334.7%
59,000
+210.0%
0.01%
+233.3%
Q1 2014$789,000
+23.5%
19,034
+15.3%
0.00%
+50.0%
Q4 2013$639,00016,5020.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q1 2019
NameSharesValueWeighting ↓
ADVANTAGE INVESTMENT MANAGEMENT, LLC 105$00.00%
Sterling Investment Advisors, Ltd. 250$00.00%
Front Row Advisors LLC 60$00.00%
Executive Wealth Management, LLC 20$00.00%
BARCLAYS PLC 1,300$00.00%
BARCLAYS PLC 33,172$10,0000.00%
HUNTINGTON NATIONAL BANK 1$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Financial Gravity Asset Management, Inc. 50$00.00%
Vectors Research Management, LLC 505$00.00%
View complete list of INSYS THERAPEUTICS INC NEW shareholders